Delivery Order SPE2DB20D7061-SPE2DB23FSQV3
Award Date 8/29/23
Potential Completion Date 8/30/23
Potential Value $2.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,605.68 to AmerisourceBergen Drug Corp for SYNVISC-One Syringe 6ml, a hyaluronic acid-based joint injection used to treat osteoarthritis symptoms. The contract, issued on September 9, 2025, with a completion date of September 10, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,985.24 to AmerisourceBergen Drug Corp for the supply of Synvisc-One syringes (6ml). This firm fixed-price delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Synvisc-One is a...
- The Defense Logistics Agency awarded a $4,205.96 delivery order to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a hyaluronic acid-based injection used for osteoarthritis knee pain management. This firm fixed price delivery order, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, was awarded competitively with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,484.36 to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used for osteoarthritis pain relief. The contract, awarded on January 29, 2026, with an ultimate completion date of January 30, 2026, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $2,560.80 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for SYNVISC-One Syringe 6ML, a hyaluronic acid-based injection used for osteoarthritis treatment. This firm fixed-price delivery order, with completion expected by September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used for knee osteoarthritis treatment. This non-set-aside, competitively awarded contract carries a ceiling value of $11,322.76 under a firm fixed price arrangement, with an ultimate completion date of August 22, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,370.86 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used for knee osteoarthritis treatment. This non-set-aside, competitively awarded contract is scheduled for completion by July 21, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,484.68 to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based injectable treatment for osteoarthritis. The contract, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's Conshohocken,...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 6 mL syringes of Synvisc-One, a hyaluronic acid injection used for knee osteoarthritis treatment. The contract, awarded November 4, 2025, carries a ceiling value of $3,463.20 and is structured as a firm fixed price delivery order with an ultimate completion date of November 5, 2025. The award was made on a non-set-aside, competitive basis, and performance will be executed from the contractor's...
- The Defense Logistics Agency awarded a $3,699.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based intra-articular injection used for knee osteoarthritis treatment. The delivery order was awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This award utilized no set-aside designation, indicating it...